8.60
+0.50
+(6.17%)
As of 11:29:36 AM GMT. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-1,769.00
-1,769.00
-1,754.00
-330.00
-1,136.00
Investing Cash Flow
1.00
1.00
-111.00
-257.00
-362.00
Financing Cash Flow
2,770.00
2,770.00
3.00
-55.00
2,647.00
End Cash Position
1,199.00
1,199.00
195.00
2,049.00
2,686.00
Capital Expenditure
-2.00
-2.00
-114.00
-258.00
-365.00
Issuance of Capital Stock
2,808.00
2,808.00
--
116.00
2,815.00
Issuance of Debt
--
--
69.00
--
14.00
Repayment of Debt
-33.00
-33.00
-62.00
-162.00
-164.00
Free Cash Flow
-1,771.00
-1,771.00
-1,868.00
-588.00
-1,501.00
3/31/2021 - 12/18/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CIZ.L Cizzle Biotechnology Holdings Plc
1.7320
+1.88%
PYC.L Physiomics Plc
1.1250
+2.27%
SYRE Spyre Therapeutics, Inc.
22.27
+1.69%
AVCT.L Avacta Group Plc
48.38
+0.79%
PASG Passage Bio, Inc.
0.5848
+1.46%
FUM.L Futura Medical plc
17.00
+3.03%
IMM.L ImmuPharma plc
5.50
+1.85%
GUTS Fractyl Health, Inc.
1.9400
-3.96%
VOR Vor Biopharma Inc.
1.3900
+0.72%
VIGL Vigil Neuroscience, Inc.
2.3500
+7.31%